Paul A Adlard

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Cerebrospinal Fluid

Mild Cognitive Impairment

Mild Traumatic Brain Injury

Top Venues

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Metallomics : integrated biometal science

The European journal of neuroscience

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Shalini S Rao, Larissa Lago, Irene Volitakis, Jay J Shukla, Gawain McColl, David I Finkelstein, Paul A Adlard
Retraction Note: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (2023)
Maria Daglas, Phan H Truong, Linh Q Miles, Sydney M A Juan, Shalini S Rao, Paul A Adlard
Deferiprone attenuates neuropathology and improves outcome following traumatic brain injury. British journal of pharmacology (2022)
Sydney M A Juan, Maria Daglas, Paul A Adlard
Altered amyloid precursor protein, tau-regulatory proteins, neuronal numbers and behaviour, but no tau pathology, synaptic and inflammatory changes or memory deficits, at 1 month following repetitive mild traumatic brain injury. The European journal of neuroscience 56 (9) (2022)
Shalini S Rao, Larissa Lago, Irene Volitakis, Jay J Shukla, Gawain McColl, David I Finkelstein, Paul A Adlard
Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 18 (2) (2021)
Shalini S Rao, Larissa Lago, Raquel Gonzalez de Vega, Lisa Bray, Dominic James Hare, David Clases, Philip A Doble, Paul A Adlard
Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy. Metallomics : integrated biometal science 12 (2) (2021)